HighLight Capital & Qiming Boost Biologics Platform
04 Jun 2025
US$ 20.00
HighLight Capital has joined Qiming Venture Partners (Qiming), an existing investor of LongBio Pharma (Suzhou) Co ......
Related Publications
Subscribers’ Weekly ending 3 Oct 2025...
Listen to Australia/New Zealand Funds (Subscribers' Weekly 03 Oct 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.